Sirolimus Solution to Tablets Conversion in Renal Transplant

Phase 4, open-label trial of sirolimus in kidney transplantation (2 arms), sponsored by National Taiwan University Hospital. Primary endpoints: Pharmacokinetics of sirolimus tablets in different regimens in de novo renal transplant patients and Effect of dosage form conversion on sirolimus concentration in stable renal transplant patients. Status: unknown.